RATIONALE
Tachycardia and hypertension are common manifestations. Tachypnea usually present with/without dyspnea. Elevated CVP may be noted before dyspnea and adventitious breath sounds occur. Hypertension may be a primary disorder or occur secondary to other associated conditions, e.g., HF.
Adventitious sounds (crackles) and extra heart sounds (S 3 ) are indicative of fluid excess. Pulmonary edema may develop rapidly.
Edema can be either a cause or a result of various pathological conditions reflecting four competing forces-blood hydrostatic and osmotic pressures, and interstitial fluid hydrostatic and osmotic pressures. The dynamic interaction of these four forces allows fluid to shift from one body compartment to another. Edema may be generalized or localized in dependent areas. Elderly patients may develop dependent edema with relatively little excess fluid. Note: Patients in a supine position can have an increase of 4-8 L of fluid before edema is readily detected.
Signs of cardiac decompensation/HF.
Decreased renal perfusion, cardiac insufficiency, and fluid shifts may cause decreased urinary output and edema formation.
ACTIONS/INTERVENTIONS

Hypervolemia Management (NIC) Independent
Weigh as indicated. Be alert for acute or sudden weight gain.
Give oral fluids with caution. If fluids are restricted, set up a 24-hr schedule for fluid intake.
Monitor infusion rate of parenteral fluids closely; administer via control device/pump as necessary.
Encourage coughing/deep-breathing exercises.
Maintain semi-Fowler's position if dyspnea or ascites is present.
Turn, reposition, and provide skin care at regular intervals.
Encourage bedrest. Schedule care to provide frequent rest periods.
Provide safety precautions as indicated, e.g., use of side rails, bed in low position, frequent observation, soft restraints (if required).
Collaborative
Assist with identification/treatment of underlying cause.
Monitor laboratory studies as indicated, e.g., electrolytes, BUN, ABGs.
Provide balanced protein, low-sodium diet. Restrict fluids as indicated.
RATIONALE
One liter of fluid retention equals a weight gain of 2.2 lb.
Fluid restrictions, as well as extracellular shifts, can aggravate drying of mucous membranes, and patient may desire more fluids than are prudent.
Sudden fluid bolus/prolonged excessive administration potentiates volume overload/risk of cardiac decompensation.
Pulmonary fluid shifts potentiate respiratory complications.
Gravity improves lung expansion by lowering diaphragm and shifting fluid to lower abdominal cavity.
Reduces pressure and friction on edematous tissue, which is more prone to breakdown than normal tissue.
Limited cardiac reserves result in fatigue/activity intolerance. In addition, lying down favors diuresis and reduction of edema.
Fluid shifts may cause cerebral edema/changes in mentation, especially in the geriatric population. Note: Application of restraints can increase agitation, requiring alternative interventions (e.g., one-on-one monitoring, sedation). Use of side rails may place the elderly confused patient at risk for entrapment injury/death.
Refer to listing of predisposing/contributing factors to determine treatment needs. Extracellular fluid shifts, sodium/water restriction, and renal function all affect serum sodium levels. Potassium deficit may occur with diuretic therapy. BUN may be increased as a result of renal dysfunction/failure. ABGs may reflect metabolic acidosis.
In presence of decreased serum proteins (e.g., malnutrition), increasing level of serum proteins can enhance colloidal osmotic gradients and promote return of fluid to the vascular space. Restriction of sodium/water decreases extracellular fluid retention.
ACTIONS/INTERVENTIONS
Hypervolemia Management (NIC)
Collaborative
Administer diuretics: loop diuretic, e.g., furosemide (Lasix); thiazide diuretic, e.g., hydrochlorothiazide (Esidrix); or potassium-sparing diuretic, e.g., spironolactone (Aldactone).
Replace potassium losses as indicated.
Prepare for/assist with dialysis or ultrafiltration, if indicated.
RATIONALE
To achieve excretion of excess fluid, either a single diuretic (e.g., thiazide) or a combination of agents (e.g., thiazide and spironolactone) may be selected. The combination can be particularly helpful when two drugs have different sites of action, allowing more effective control of fluid excess.
Potassium deficit may occur, especially if patient is receiving potassium-wasting diuretic. This can cause lethal cardiac dysrhythmias if untreated.
May be done to rapidly reduce fluid overload, especially in the presence of severe cardiac/renal failure. Ascertain patient's beverage preferences, and set up a 24-hr schedule for fluid intake. Encourage foods with high fluid content.
Hypovolemia (Extracellular Fluid Volume Deficit)
PREDISPOSING/CONTRIBUTING FACTORS
Turn frequently, massage skin, and protect bony prominences.
Provide skin and mouth care. Bathe every other day using mild soap. Apply lotion as indicated.
RATIONALE
Tachycardia is present along with a varying degree of hypotension, depending on degree of fluid deficit. CVP measurements are useful in determining degree of fluid deficit and response to replacement therapy. Fever increases metabolism and exacerbates fluid loss.
Conditions that contribute to extracellular fluid deficit can result in inadequate organ perfusion to all areas and may cause circulatory collapse/shock. Although weight gain and fluid intake higher than output may not accurately reflect intravascular volume, e.g., third-space fluid accumulation cannot be used by the body for tissue perfusion, these measurements provide useful data for comparison.
Impaired gag/swallow reflexes, anorexia/nausea, oral discomfort, and changes in level of consciousness/ cognition are among the factors that affect patient's ability to replace fluids orally.
Relieves thirst and discomfort of dry mucous membranes and augments parenteral replacement.
Tissues are susceptible to breakdown because of vasoconstriction and increased cellular fragility.
Skin and mucous membranes are dry, with decreased elasticity, because of vasoconstriction and reduced intracellular water. Daily bathing may increase dryness.
Decreased cerebral perfusion frequently results in changes in mentation/altered thought processes, requiring protective measures to prevent patient injury. Note: Application of restraints can increase agitation, requiring alternative interventions (e.g., one-on-one monitoring, sedation). Use of side rails may place the elderly confused patient at risk for entrapment injury/death.
ACTIONS/INTERVENTIONS
Hypovolemia Management (NIC)
Independent
Investigate reports of sudden/sharp chest pain, dyspnea, cyanosis, increased anxiety, restlessness.
Monitor for sudden/marked elevation of BP, restlessness, moist cough, dyspnea, basalar crackles, frothy sputum.
Collaborative
Monitor laboratory studies as indicated, e.g., electrolytes, glucose, pH/Pco 2 , coagulation studies.
Administer IV solutions as indicated:
Isotonic solutions, e.g., 0.9% NaCl (normal saline), 5% dextrose/water; 0.45% NaCl (half-normal saline), lactated Ringer's (LR) solution;
Colloids, e.g., dextran, Plasmanate/albumin, hetastarch (Hespan);
Whole blood/packed RBC transfusion, or autologous collection of blood.
Administer sodium bicarbonate, if indicated.
Provide tube feedings, including free water as appropriate.
RATIONALE
Hemoconcentration (sludging) and increased platelet aggregation may result in systemic emboli formation.
Too rapid a correction of fluid deficit may compromise the cardiopulmonary system, especially if colloids are used in general fluid replacement (increased osmotic pressure potentiates fluid shifts).
Refer to listing of predisposing/contributing factors to determine treatment needs.
Depending on the avenue of fluid loss, differing electrolyte/metabolic imbalances may be present/require correction; e.g., use of glucose solutions in patients with underlying glucose intolerance may result in serum glucose elevation and increased urinary water losses.
Note: Hypodermoclysis (rehydration via subcutaneous infusion) may be indicated to correct fluid deficits without the stress of IV therapy/enteral tubes or hospitalization, especially for elderly patients.
Crystalloids provide prompt circulatory improvement, although the benefit may be transient (increased renal clearance).
As soon as patient is normotensive, a hypotonic solution (0.45% NaCl) may be used to provide both electrolytes and free water for renal excretion of metabolic wastes. Note: Buffered crystalloids (LR) are used with caution because they may potentiate the risk of metabolic acidosis.
Corrects plasma protein concentration deficits, thereby increasing intravascular osmotic pressure and facilitating return of fluid into vascular compartment.
Indicated when hypovolemia is related to active blood loss.
May be given to correct severe acidosis while correcting fluid balance.
Enteral replacement can provide proteins and other needed elements in addition to meeting general fluid requirements when swallowing is impaired.
SODIUM
Sodium (Na) is the major cation of extracellular fluid and is primarily responsible for osmotic pressure in that compartment. Sodium enhances neuromuscular conduction/transmission of impulses and is essential for maintaining acid-base balance. Normal serum range is 135-145 mEq/L; intracellular, 10 mEq/L. Chloride is carried by Na and will display the same imbalances. Normal serum chloride range is 95-105 mEq/L.
Hyponatremia (Sodium Deficit)
Predisposing/contributing factors Primary hyponatremia (loss of sodium): Lack of sufficient dietary sodium, severe malnutrition, infusion of sodium-free solutions; excessive sodium loss through heavy sweating (e.g., heat exhaustion), wounds/trauma (hemorrhage), burns, gastric suctioning, vomiting, diarrhea, small-bowel obstruction, peritonitis, salt-wasting renal dysfunction, adrenal insufficiency (Addison's disease) Dilutional hyponatremia (water gains): Excessive water intake, electrolyte-free IV infusion, water intoxication (IV therapy, tap-water enemas), gastric irrigations with electrolyte-free solutions, presence of tumors or CNS disorders predisposing to SIADH, HF, renal failure/nephrotic syndrome, hepatic cirrhosis, DM (hyperglycemia), freshwater near-drowning; use of certain drugs, e.g., hypoglycemia medications, barbiturates, antipsychotics, aminophylline, morphine (may stimulate pituitary gland to secrete excessive amounts of ADH), anticonvulsants, some antineoplastic agents, or NSAIDs Note: A pseudohyponatremia may occur in presence of multiple myeloma, hyperlipidemia, or hypoproteinemia but does not reflect an actual abnormality of water metabolism.
Patient Assessment Database
(Patient may be asymptomatic until serum sodium level is less than 125 mEq/L, depending on rapidity of onset.) 
General
ACTIVITY/REST
DIAGNOSTIC STUDIES (DEPEND ON ASSOCIATED FLUID LEVEL)
Serum sodium: Decreased, less than 135 mEq/L. However, signs/symptoms may not occur until level is less than 120 mEq/L. Urine sodium: Less than 15 mEq/L indicates renal conservation of sodium because of sodium loss from a nonrenal source unless sodium-wasting nephropathy is present. Urine sodium higher than 20 mEq/L indicates SIADH. Serum potassium: May be decreased as the kidneys attempt to conserve sodium at the expense of potassium. Serum chloride/bicarbonate: Levels are decreased, depending on which ion is lost with the sodium. Serum osmolality: Commonly low, but may be normal (pseudohyponatremia) or high (HHNC). Urine osmolality: Usually less than 100 mOsm/L unless SIADH present, in which case it will exceed serum osmolality. Urine specific gravity: May be decreased (less than 1.010) or increased (higher than 1.020) if SIADH is present. Hct: Depends on fluid balance, e.g., fluid excess versus dehydration.
DESIRED OUTCOMES/EVALUATION CRITERIA-PATIENT WILL:
Electrolyte & Acid/Base Balance (NOC) Display heart rate, BP, and laboratory results within normal limits (WNL) for patient; absence of muscle weakness, neurological irritability.
ACTIONS/INTERVENTIONS
Electrolyte Management: Hyponatremia (NIC)
Independent
Identify patient at risk for hyponatremia and the specific cause, e.g., sodium loss or fluid excess.
Monitor I&O. Calculate fluid balance. Weigh daily.
Assess level of consciousness/neuromuscular response.
Maintain quiet environment; provide safety/seizure precautions.
Note respiratory rate and depth.
Encourage foods and fluids high in sodium, e.g., milk, meat, eggs, carrots, beets, and celery. Use fruit juices and bouillon instead of plain water.
RATIONALE
Provides clues for early intervention. Hyponatremia is a common imbalance (especially in the elderly) and may range from mild to severe. Severe hyponatremia can cause neurological damage or death if not treated promptly.
Indicators of fluid balance are important, because either fluid excess or deficit may occur with hyponatremia.
Sodium deficit may result in decreased mentation (to point of coma), as well as generalized muscle weakness/cramps, convulsions.
Reduces CNS stimulation and risk of injury from neurological complications, e.g., seizures.
Co-occurring hypochloremia may produce slow/shallow respirations as the body compensates for metabolic alkalosis.
Unless sodium deficit causes serious symptoms requiring immediate IV replacement, patient may benefit from slower replacement by oral method or removal of previous salt restriction.
ACTIONS/INTERVENTIONS
Independent
Irrigate NG tube (when used) with normal saline instead of water.
Observe for signs of circulatory overload as indicated.
Collaborative
Monitor serum and urine electrolytes, osmolality.
Provide/restrict fluids depending on fluid volume status.
Administer medications as indicated, e. Prepare for/assist with dialysis as indicated.
RATIONALE
Isotonic irrigation will minimize loss of GI electrolytes.
Administration of sodium-containing IV fluids in presence of HF increases risk.
Evaluates therapy needs/effectiveness.
In presence of hypovolemia, volume losses are replaced with isotonic saline (e.g., normal saline), or, on occasion, hypertonic solution (3% NaCl) when hyponatremia is life-threatening. In the presence of fluid volume excess, or SIADH, fluid restriction is indicated. Note: Too rapid/excessive administration of hypertonic solutions can be lethal.
Effective in reducing fluid excess to correct sodium/water balance.
Used to replace deficits/prevent recurrence in the presence of chronic/ongoing losses.
Corrects potassium deficit, especially when diuretic is used.
Useful in treating chronic SIADH, or when severe water restriction may not be tolerated, e.g., COPD. Note: May be contraindicated in patients with liver disease, because nephrotoxicity may occur.
May be used in combination with a loop diuretic (e.g., Lasix) to correct fluid volume excess, especially in the presence of HF.
May be done to restore sodium balance without increasing fluid level when hyponatremia is severe or response to diuretic therapy is inadequate.
Hypernatremia (Sodium Excess)
Predisposing/contributing factors Excessive water losses: Polyuria (as may occur with diabetes insipidus); use of osmotic diuretics (such as mannitol); presence of fever, profuse sweating, vomiting, diarrhea; extracellular fluid volume excesses: e.g., renal disease, HF, primary aldosteronism, excessive steroids/Cushing's disease; excessive ingestion or infusion of sodium; salt-water near-drowning
ACTIONS/INTERVENTIONS
Electrolyte Management: Hypernatremia (NIC)
Independent
Monitor BP.
Identify patient at risk for hypernatremia and likely cause, e.g., water deficit, sodium excess.
Note respiratory rate, depth.
Monitor I&O, urine specific gravity. Weigh daily. Assess presence/location of edema.
RATIONALE
Either hypertension or hypotension may be present, depending on the fluid status. Presence of postural hypotension may affect activity tolerance.
Early identification and intervention prevents serious complications associated with this problem.
Deep, labored respirations with air hunger suggest metabolic acidosis (hyperchloremia), which can lead to cardiopulmonary arrest if not corrected.
These parameters are variable, depending on fluid status, and are indicators of therapy needs/effectiveness.
ACTIONS/INTERVENTIONS
Independent
Evaluate level of consciousness and muscular strength, tone, movement.
Maintain safety/seizure precautions, as indicated, e.g., bed in low position, use of padded side rails.
Assess skin turgor, color, temperature, and mucous membrane moisture.
Provide/encourage meticulous skin care and frequent repositioning.
Provide frequent oral care. Avoid use of mouthwash/rinse that contains alcohol.
Offer debilitated patient fluids at regular intervals. Give free water to patient receiving enteral feedings.
Recommend avoidance of foods high in sodium, e.g., canned soups/vegetables, processed foods, snack foods, and condiments.
Collaborative
Monitor serum electrolytes, osmolality, and ABGs as indicated.
Increase PO/IV fluid intake, e.g., 5% dextrose/water in presence of dehydration; 0.9% NaCl if extracellular deficit is present.
Restrict sodium intake and administer diuretics as indicated.
RATIONALE
Sodium imbalance may cause changes that vary from confusion and irritability to seizures and coma. In presence of water deficit, rapid rehydration may cause cerebral edema.
Sodium excess/cerebral edema increases risk of convulsions.
Water-deficit hyperatremia manifests by signs of dehydration.
Maintains skin integrity.
Promotes comfort and prevents further drying of mucous membranes.
May prevent hypernatremia in patient who is unable to perceive or respond to thirst.
Reduces risk of sodium-associated complications.
Evaluates therapy needs/effectiveness. Note: Cooccurring hyperchloremia may cause metabolic acidosis, requiring buffering, e.g., sodium bicarbonate.
Replacement of total body water deficit will gradually restore sodium/water balance. Note: Rapid reduction of serum sodium level with corresponding decrease in serum osmolality can cause cerebral edema/convulsions.
Restriction of sodium intake while promoting renal clearance lowers serum sodium levels in the presence of extracellular fluid excess.
POTASSIUM
Potassium is the major cation of the intracellular fluid and is responsible for maintaining intracellular osmotic pressure. Potassium also regulates neuromuscular excitability, aids in maintenance of acid-base balance, synthesis of protein, and metabolism of carbohydrates. Normal serum range is 3.5-5.0 mEq/L (body total of 42 mEq/L). 
Hypokalemia (Potassium Deficit)
PREDISPOSING/CONTRIBUTING FACTORS
ACTIONS/INTERVENTIONS
Electrolyte Management: Hypokalemia (NIC)
Independent
Monitor heart rate/rhythm.
Monitor respiratory rate, depth, effort. Encourage cough/deep-breathing exercises; reposition frequently.
Assess level of consciousness and neuromuscular function, e.g., strength, sensation, movement.
Auscultate bowel sounds, noting decrease/absence or change.
Maintain accurate record of urinary, gastric, and wound losses.
Monitor rate of IV potassium administration using microdrop or pump infusion devices. Check for side effects. Provide ice pack as indicated.
RATIONALE
Changes associated with hypokalemia include abnormalities in both conduction and contractility. Tachycardia may develop, and potentially life-threatening atrial and ventricular dysrhythmias, e.g., PVCs, sinus bradycardia, atrioventricular (AV) blocks, AV dissociation, ventricular tachycardia.
Respiratory muscle weakness may proceed to paralysis and eventual respiratory arrest.
Apathy, drowsiness, irritability, tetany, paresthesias, and coma may occur.
Paralytic ileus commonly follows gastric losses through vomiting/gastric suction, protracted diarrhea.
Guide for calculating fluid/potassium replacement needs.
Ensures controlled delivery of medication to prevent bolus effect and reduce associated discomfort, e.g., burning sensation at IV site. When solution cannot be administered via central vein and slowing rate is not possible/effective, ice pack to infusion site may help relieve discomfort.
ACTIONS/INTERVENTIONS
Independent
Encourage intake of foods and fluids high in potassium, e.g., bananas, oranges, dried fruits, red meat, turkey, salmon, leafy vegetables, peas, baked potatoes, tomatoes, winter squash, coffee, colas, tea. Discuss use of potassium chloride salt substitutes for patient receiving long-term diuretics.
Review drug regimen for potassium-wasting drugs, e.g., furosemide (Lasix), hydrochlorothiazide (Esidrix), Acetazolamide (Diamox), IV catecholamines, gentamicin (Garamycin), carbenicillin (Geocillin), amphotericin B (Fungizone).
Discuss preventable causes of condition, e.g., nutritional choices, proper use of laxatives.
Dilute liquid and effervescent potassium supplements (KTab, K-Lyte/Cl) with 4 oz water/juice and give after meals.
Watch for signs of digitalis intoxication when used (e.g., reports of nausea/vomiting, blurred vision, increasing atrial dysrhythmias, and heart block).
Observe for signs of metabolic alkalosis, e.g., hypoventilation, tachycardia, dysrhythmias, tetany, changes in mentation.
Collaborative
Monitor laboratory studies, e.g.: Serum potassium;
ABGs; RATIONALE Potassium may be replaced/level maintained through the diet when patient is allowed oral food and fluids. Dietary replacement of 40-60 mEq/L/day is typically sufficient if no abnormal losses are occurring.
If alternative agents, e.g., potassium-sparing diuretics such as spirinolactone (Aldactone), triamterene (Dyrenium), amiloride (Midamor), cannot be administered or when high-dose sodium drugs are administered (e.g., carbenicillin), close monitoring and replacement of potassium are necessary.
Provides opportunity for patient to prevent recurrence. Also, dietary control is more palatable than oral replacement medications.
May prevent/reduce GI irritation and saline laxative effect.
Low potassium enhances effect of digitalis, slowing cardiac conduction. Note: Combined effects of digitalis, diuretics, and hypokalemia may produce lethal dysrhythmias.
Frequently associated with hypokalemia and requiring additional correction.
Refer to listing of predisposing/contributing factors to determine treatment needs. Note: Hypokalemia is lifethreatening, early detection is crucial.
Levels should be checked frequently during replacement therapy, especially in the presence of insufficient renal function. Sudden excess/elevation may cause cardiac dysrhythmias.
Correction of metabolic alkalosis raises serum potassium level and reduces replacement needs. Correction of acidosis drives potassium back into cells, resulting in decreased serum levels and increased replacement needs. Administer oral and/or IV potassium.
ACTIONS/INTERVENTIONS
RATIONALE
Hypomagnesemia occurs with and exacerbates potassium loss and sodium retention, altering cell membrane excitability (affects cardiac and neuromuscular function).
Use of diuretics, e.g., furosemide (Lasix), hydrochlorothiazide (HydroDIURIL), may cause chloride and potassium depletion.
May be required to correct deficiencies when changes in medication, therapy, and/or dietary intake are insufficient. Note: Even in severe deficit, parenteral replacement should not exceed 40 mEq/2 hr. Dietary supplementation may also be used to produce a gradual equilibration if patient is able to take oral food and fluids.
Hyperkalemia (Potassium Excess)
PREDISPOSING/CONTRIBUTING FACTORS
Potassium retention: Decreased renal excretion (e.g., renal disease/acute failure, hypoaldosteronism, Addison's disease), hypovolemia, use of potassium-conserving diuretics, especially when associated with potassium supplements, use of NSAIDs Excessive potassium intake: Salt substitutes, nutrition supplementation shakes, drugs containing potassium (e.g., penicillin), improper use of oral potassium supplements, too-rapid IV administration of potassium, massive transfusion of banked blood Shift or release of potassium out of cells: Severe catabolism, burns, crush injuries, myocardial infarction (MI), severe hemolysis, rhabdomyolysis, chemotherapy with cytotoxic drugs, respiratory or metabolic acidosis, anoxia, hyperglycemia with insulin deficiency, use of some [beta]-adrenergic blockers, profound digitalis toxicity Other: Use of certain medications such as captopril, heparin, cyclosporine
Patient Assessment Database
Data depend on degree of elevation and length of time condition has existed.
RATIONALE
Patients may hypoventilate and retain CO 2 , leading to respiratory acidosis. Muscular weakness can affect respiratory muscles and lead to complications of respiratory infection/failure.
Excess potassium depresses myocardial conduction. Bradycardia can progress to cardiac fibrillation/arrest.
In kidney failure, potassium is retained because of improper excretion. Potassium should not be given if oliguria or anuria is present.
Patient is usually awake and alert; however, muscular paresthesia, weakness, and flaccid paralysis may occur.
Improves muscular tone and reduces muscle cramps and pain.
General muscle weakness decreases activity tolerance.
Requires regular monitoring of potassium levels, and may require alternative drug choices or changes in dosage/frequency.
Facilitates reduction of potassium level and may prevent recurrence of hyperkalemia.
Reduces exogenous sources of potassium and prevents catabolic tissue breakdown with release of cellular potassium.
May help prevent recurrence.
Evaluates therapy needs/effectiveness. Note: Hypoventilation may result in respiratory acidosis, thereby increasing serum potassium levels. [beta]-adrenergic agonist, e.g., albuterol (Proventil).
ACTIONS/INTERVENTIONS
Infuse potassium-based medication/solutions slowly.
Provide fresh blood or washed RBCs (when possible) if transfusions required.
Prepare for/assist with dialysis (peritoneal or hemodialysis).
RATIONALE
Loop or thiazide diuretics promote renal clearance and excretion of potassium.
Short-term emergency measure to move potassium into the cell, thus reducing toxic serum level. Note: Use with caution in presence of HF or hypernatremia. Use of glucose is contraindicated in patients who are hyperkalemic.
Temporary stopgap measure that antagonizes toxic potassium depressant effects on heart and stimulates cardiac contractility. Note: Calcium is contraindicated in patients on digitalis because it increases the cardiotonic effects of the drug and may cause dysrhythmias.
Resin removes potassium by exchanging potassium for sodium or calcium in the GI tract. Sorbitol enhances evacuation. Note: Use cautiously in patients with HF, edema, and in the elderly because it increases sodium level. In addition, Kayexalate may cause hyperchloremia.
Nebulizer administration has been effective in patients receiving hemodialysis, and may also attentuate the hypoglycemic effect of insulin administration.
Prevents administration of concentrated bolus, allows time for kidneys to clear excess free potassium.
Fresh blood has less potassium than banked blood, because breakdown of older RBCs releases potassium.
May be required when more conservative methods fail or are contraindicated, e.g., severe HF.
CALCIUM
Calcium is involved in bone formation/reabsorption, neural transmission/muscle contraction, regulation of enzyme systems, and is a coenzyme in blood coagulation. Normal serum levels are 4.5-5.3 mEq/L, 8.5-10.5 mg/dL (total) or 2.1-2.6 mEq/L (ionized). The ionized calcium is physiologically active and clinically important, especially in critically ill patients. The total serum calcium is directly related to the serum albumin, follows it, and must be considered if only total serum readings are available. Some factors that alter the percentage of ionized calcium are changes in pH (affects how much calcium is bound to protein) or increased serum levels of fatty acids, lactate, and bicarbonate.
Hypocalcemia (Calcium Deficit)
PREDISPOSING/CONTRIBUTING FACTORS 
Collaborative
Monitor laboratory studies, e.g.:
Serum calcium and magnesium; serum albumin, ABGs;
PT, platelets.
RATIONALE
Tetany can be potentiated by hyperventilation and stress. Note: Direct pressure on the nerves (e.g., tightening BP cuff) may also cause tetany.
Alterations in coagulation can occur as a result of calcium deficiency.
Some drugs can lower magnesium levels, affecting calcium level. The effect of digitalis is enhanced by calcium, and, in patients receiving calcium, digitalis intoxication may develop.
Those containing phosphate may negatively affect calcium metabolism.
Insufficient ingestion of vitamin D and fat impairs absorption of calcium.
Vitamin D aids in absorption of calcium from intestinal tract. Phosphorus competes with calcium for intestinal absorption.
Possible sources for oral replacement to help maintain calcium levels, especially in patients at risk for osteoporosis.
Adverse effects of long-term deficiency include tooth decay, eczema, cataracts, and osteoporosis.
Evaluates therapy needs/effectiveness. Note: Low serum albumin levels or serum pH affects calcium levels, e.g., a low albumin level causes a deceptively low calcium level; alkalosis causes surplus bicarbonate to bind with free calcium, impairing function; acidosis frees calcium, potentiating hypercalcemia.
Calcium is an essential part of the clotting mechanism and deficit may lead to excessive bleeding.
